Your institution may have access to this item. Find your institution then sign in to continue.
Title
High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial
Authors
Yazdanpanah, Y.; Fagard, C.; Descamps, D.; Taburet, A. M.; Colin, C.; Roquebert, B.; Katlama, C.; Pialoux, G.; Jacomet, C.; Piketty, C.; Bollens, D.; Molina, J. M.; Chêne, G.